Next-generation Sequencing Market Size, Share & Industry Analysis
商品番号 : SMB-72359
| 出版社 | Fortune Business Insights |
| 出版年月 | 2025年1月 |
| ページ数 | 145 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,850 |
| 種別 | 英文調査報告書 |
Growth Factors of Next-generation Sequencing Market
The next-generation sequencing market size was valued at USD 8.30 billion in 2023, and the market is now projected to grow from USD 9.29 billion in 2024 to USD 27.55 billion by 2032, exhibiting a CAGR of 14.6% during the forecast period of 2024-2032.
次世代シーケンシング（NGS）の市場規模は2023年に83億米ドルと評価され、現在市場は2024年の92億9000万米ドルから2032年までに275億5000万米ドルに成長すると予測されており、2024-2032年の予測期間中に14.6%のCAGRを示します。
The unexpected emergence of COVID-19 positively affected the next-generation sequencing market growth since the virus was easily spread. Hence there was a need to diagnose it using next-generation sequencing instruments. It supported and pushed for faster development of the vaccines and funding for it. Scientific research related to genomes was also learned during this phase. It has been asserted that sustained adoption of such technologies is expected to drive this market post-pandemic. This trend helps maintain progressive development and increasing innovation in this sector.
Developing next-generation sequencing (NGS) in the diagnostics segment is a key factor driving growth. Due to the decrease in sequencing costs, the use of disease diagnoses such as cancer or genetic diagnostic tests has broadened. Organisations are also bringing out new test kits and services. Government approvals and improvements in the reimbursement policies for next-generation sequencing escalate market share. The increase in chronic diseases and continuous research make the next-generation sequencing market share.
Additionally, governments are increasingly funding genome projects, boosting the next-generation sequencing (NGS) market. NGS has transformed disease diagnosis and management over the past decade. This technology plays a vital role in advancing healthcare. Global investments in genomics drive market growth. Such initiatives enhance disease research and innovation
Comprehensive Analysis of Next-generation Sequencing Market
The next-generation sequencing market and healthcare industry is rising at an exponential rate due to its market segmentation. This market expansion effectively provides a detailed regional assessments considering the dominant supply and demand forces that impact the healthcare industry. These segmentations are methodically segregated by Types, by Technology, by Application and by End-User. The type includes, Products {Instruments & Consumables} and Services. The technology includes, Sequencing By Synthesis (SBS), Nanopore Sequencing, ION Semiconductor Sequencing and Others. The application includes, Research & Applied and Clinical {Cardiovascular, Oncology, Genetic Diseases, Reproductive Health and Others}. The end- user includes, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes and Others.
The North American market is recognized as the largest region for next-generation sequencing worth USD 4.60 billion in 2023. The region’s dominance is amplified by robust genomics research, investment in research and development and the existence of companies. New products, services, and strategic alliances also provide other ways to escalate growth. The market is expected to sustain its dominance during this study. Further, innovations and collaboration will remain key to future developments and expansion.
The top players in the market play a crucial role in the healthcare industry assuring industrial prospectus growth and setting market standards. These players include, Illumina Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), QIAGEN (Germany), PacBio (U.S.), Oxford Nanopore Technologies (U.K.), Perkin Elmer, Inc. (U.S.) and BGI (China). These market players provide a level-playing competitive landscape.
In February 2024, IDT worked closely with Element Biosciences, Inc. to enhance NGS workflows by making them less complex.
Segmentation Table
Global Point of Care CT Imaging Systems Market Scope
Study Period 2019-2032
Base Year 2023
Forecast Period 2024-2032
Growth Rate CAGR of 14.6% from 2024-2032
Historical Period 2019-2022
Unit Value (USD Billion)
Segmentation By Type, Technology, Application, End-User and Region
By Type
- Products
o Instruments
o Consumables
- Services
By Technology
- Sequencing By Synthesis (SBS)
- Nanopore Sequencing
- ION Semiconductor Sequencing
- Others
By Application
- Research & Applied
- Clinical
o Cardiovascular
o Oncology
o Genetic Diseases
o Reproductive Health
By End- User
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Others
By Region
- North America (By Type, Technology, Application, End-User, and Country)
o U.S.
o Canada
- Europe (By Type, Technology, Application, End-User, and Country/ Sub-Region)
o U.K.
o Germany
o France
o Italy
o Spain
o Scandinavia
o Rest of Europe
- Asia Pacific (By Type, Technology, Application, End-User, and Country/ Sub-Region)
o China
o Japan
o India
o Australia
o Southeast Asia
o Rest of the Asia Pacific
- Latin America (By Type, Technology, Application, End-User, and Country/ Sub-Region)
o Brazil
o Mexico
o Rest of Latin America
- Middle East & Africa (By Type, Technology, Application, End-User, and Country/ Sub-Region)
o GCC
o South Africa
o Rest of the Middle East & Africa
Table of Contents
1. Introduction
1.1. Market Scope
1.2. Market Segmentation
1.3. Market Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Market Trends
4. Key Insights
4.1. Prevalence of Key Diseases, By Key Countries, 2023
4.2. Overview: Regulatory Scenario & Reimbursement Scenario, By Key Countries/Region
4.3. New Product Launches, By Key Players
4.4. Key Industry Developments, By Key Players
4.5. Overview: Technological Advancements in Next-generation Sequencing
4.6. Impact of COVID-19 on the Market
5. Global Next-generation Sequencing Market Analysis, Insights and Forecast, 2019-2032
5.1. Market Analysis, Insights and Forecast – By Type
5.1.1. Products
5.1.1.1. Instruments
5.1.1.2. Consumables
5.1.2. Services
5.2. Market Analysis, Insights and Forecast – By Technology
5.2.1. Sequencing By Synthesis (SBS)
5.2.2. Nanopore Sequencing
5.2.3. ION Semiconductor Sequencing
5.2.4. Others
5.3. Market Analysis, Insights and Forecast – By Application
5.3.1. Research & Applied
5.3.2. Clinical
5.3.2.1. Cardiovascular
5.3.2.2. Oncology
5.3.2.3. Genetic Diseases
5.3.2.4. Reproductive Health
5.4. Market Analysis, Insights and Forecast – By End User
5.4.1. Pharmaceutical & Biotechnology Companies
5.4.2. Academic & Research Institutes
5.4.3. Others
5.5. Market Analysis, Insights and Forecast – By Region
5.5.1. North America
5.5.2. Europe
5.5.3. Asia Pacific
5.5.4. Latin America
5.5.5. Middle East & Africa
6. North America Next-generation Sequencing Market Analysis, Insights and Forecast, 2019-2032
6.1. Market Analysis, Insights and Forecast – By Type
6.1.1. Products
6.1.1.1. Instruments
6.1.1.2. Consumables
6.1.2. Services
6.2. Market Analysis, Insights and Forecast – By Technology
6.2.1. Sequencing By Synthesis (SBS)
6.2.2. Nanopore Sequencing
6.2.3. ION Semiconductor Sequencing
6.2.4. Others
6.3. Market Analysis, Insights and Forecast – By Application
6.3.1. Research & Applied
6.3.2. Clinical
6.3.2.1. Cardiovascular
6.3.2.2. Oncology
6.3.2.3. Genetic Diseases
6.3.2.4. Reproductive Health
6.4. Market Analysis, Insights and Forecast – By End User
6.4.1. Pharmaceutical & Biotechnology Companies
6.4.2. Academic & Research Institutes
6.4.3. Others
6.5. Market Analysis, Insights and Forecast – By Country
6.5.1. U.S.
6.5.2. Canada
7. Europe Next-generation Sequencing Market Analysis, Insights and Forecast, 2019-2032
7.1. Market Analysis, Insights and Forecast – By Type
7.1.1. Products
7.1.1.1. Instruments
7.1.1.2. Consumables
7.1.2. Services
7.2. Market Analysis, Insights and Forecast – By Technology
7.2.1. Sequencing By Synthesis (SBS)
7.2.2. Nanopore Sequencing
7.2.3. ION Semiconductor Sequencing
7.2.4. Others
7.3. Market Analysis, Insights and Forecast – By Application
7.3.1. Research & Applied
7.3.2. Clinical
7.3.2.1. Cardiovascular
7.3.2.2. Oncology
7.3.2.3. Genetic Diseases
7.3.2.4. Reproductive Health
7.4. Market Analysis, Insights and Forecast – By End User
7.4.1. Pharmaceutical & Biotechnology Companies
7.4.2. Academic & Research Institutes
7.4.3. Others
7.5. Market Analysis, Insights and Forecast – By Country/Sub-region
7.5.1. U.K
7.5.2. Germany
7.5.3. France
7.5.4. Spain
7.5.5. Italy
7.5.6. Scandinavia
7.5.7. Rest of Europe
8. Asia Pacific Next-generation Sequencing Market Analysis, Insights and Forecast, 2019-2032
8.1. Market Analysis, Insights and Forecast – By Type
8.1.1. Products
8.1.1.1. Instruments
8.1.1.2. Consumables
8.1.2. Services
8.2. Market Analysis, Insights and Forecast – By Technology
8.2.1. Sequencing By Synthesis (SBS)
8.2.2. Nanopore Sequencing
8.2.3. ION Semiconductor Sequencing
8.2.4. Others
8.3. Market Analysis, Insights and Forecast – By Application
8.3.1. Research & Applied
8.3.2. Clinical
8.3.2.1. Cardiovascular
8.3.2.2. Oncology
8.3.2.3. Genetic Diseases
8.3.2.4. Reproductive Health
8.4. Market Analysis, Insights and Forecast – By End User
8.4.1. Pharmaceutical & Biotechnology Companies
8.4.2. Academic & Research Institutes
8.4.3. Others
8.5. Market Analysis, Insights and Forecast – By Country/Sub-region
8.5.1. Japan
8.5.2. China
8.5.3. India
8.5.4. Australia
8.5.5. Southeast Asia
8.5.6. Rest of Asia Pacific
9. Latin America Next-generation Sequencing Market Analysis, Insights and Forecast, 2019-2032
9.1. Market Analysis, Insights and Forecast – By Type
9.1.1. Products
9.1.1.1. Instruments
9.1.1.2. Consumables
9.1.2. Services
9.2. Market Analysis, Insights and Forecast – By Technology
9.2.1. Sequencing By Synthesis (SBS)
9.2.2. Nanopore Sequencing
9.2.3. ION Semiconductor Sequencing
9.2.4. Others
9.3. Market Analysis, Insights and Forecast – By Application
9.3.1. Research & Applied
9.3.2. Clinical
9.3.2.1. Cardiovascular
9.3.2.2. Oncology
9.3.2.3. Genetic Diseases
9.3.2.4. Reproductive Health
9.4. Market Analysis, Insights and Forecast – By End User
9.4.1. Pharmaceutical & Biotechnology Companies
9.4.2. Academic & Research Institutes
9.4.3. Others
9.5. Market Analysis, Insights and Forecast – By Country/Sub-region
9.5.1. Brazil
9.5.2. Mexico
9.5.3. Rest of Latin America
10. Middle East & Africa Next-generation Sequencing Market Analysis, Insights and Forecast, 2019-2032
10.1. Market Analysis, Insights and Forecast – By Type
10.1.1. Products
10.1.1.1. Instruments
10.1.1.2. Consumables
10.1.2. Services
10.2. Market Analysis, Insights and Forecast – By Technology
10.2.1. Sequencing By Synthesis (SBS)
10.2.2. Nanopore Sequencing
10.2.3. ION Semiconductor Sequencing
10.2.4. Others
10.3. Market Analysis, Insights and Forecast – By Application
10.3.1. Research & Applied
10.3.2. Clinical
10.3.2.1. Cardiovascular
10.3.2.2. Oncology
10.3.2.3. Genetic Diseases
10.3.2.4. Reproductive Health
10.4. Market Analysis, Insights and Forecast – By End User
10.4.1. Pharmaceutical & Biotechnology Companies
10.4.2. Academic & Research Institutes
10.4.3. Others
10.5. Market Analysis, Insights and Forecast – By Country/Sub-region
10.5.1. GCC
10.5.2. South Africa
10.5.3. Rest of Middle East & Africa
11. Competitive Analysis
11.1. Global Market Share Analysis (2023)
11.2. Company Profiles
11.2.1. Illumina Inc.
11.2.1.1. Overview
11.2.1.2. Products & services
11.2.1.3. SWOT Analysis
11.2.1.4. Recent Developments
11.2.1.5. Strategies
11.2.1.6. Financials (Based on Availability)
11.2.2. Thermo Fisher Scientific Inc.
11.2.2.1. Overview
11.2.2.2. Products & services
11.2.2.3. SWOT Analysis
11.2.2.4. Recent Developments
11.2.2.5. Strategies
11.2.2.6. Financials (Based on Availability)
11.2.3. F. Hoffmann-La Roche Ltd.
11.2.3.1. Overview
11.2.3.2. Products & services
11.2.3.3. SWOT Analysis
11.2.3.4. Recent Developments
11.2.3.5. Strategies
11.2.3.6. Financials (Based on Availability)
11.2.4. QIAGEN
11.2.4.1. Overview
11.2.4.2. Products & services
11.2.4.3. SWOT Analysis
11.2.4.4. Recent Developments
11.2.4.5. Strategies
11.2.4.6. Financials (Based on Availability)
11.2.5. PacBio
11.2.5.1. Overview
11.2.5.2. Products & services
11.2.5.3. SWOT Analysis
11.2.5.4. Recent Developments
11.2.5.5. Strategies
11.2.5.6. Financials (Based on Availability)
11.2.6. Oxford Nanopore Technologies
11.2.6.1. Overview
11.2.6.2. Products & services
11.2.6.3. SWOT Analysis
11.2.6.4. Recent Developments
11.2.6.5. Strategies
11.2.6.6. Financials (Based on Availability)
11.2.7. Perkin Elmer, Inc.
11.2.7.1. Overview
11.2.7.2. Products & services
11.2.7.3. SWOT Analysis
11.2.7.4. Recent Developments
11.2.7.5. Strategies
11.2.7.6. Financials (Based on Availability)
11.2.8. BGI
11.2.8.1. Overview
11.2.8.2. Products & services
11.2.8.3. SWOT Analysis
11.2.8.4. Recent Developments
11.2.8.5. Strategies
11.2.8.6. Financials (Based on Availability)
Fortune Business Insights（フォーチュンビジネスインサイツ）は多様な産業を対象に市場調査を行い、市場動向、競争環境、将来予測などを盛り込んだ市場調査レポートを出版しています。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
| シングルユーザ | マルチユーザ | エンタープライズ |
| USD4,850 | USD5,850 | USD6,850 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス ※レポートタイトルにより異なる場合がございます。詳細はお問合せください。
- シングルユーザライセンス
- 提供ファイル：PDF（印刷不可）
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 提供ファイル：PDF（印刷不可）＋Excel（印刷不可）
- 同一企業内6名までレポートファイルのご共有が可能です。
- エンタープライズライセンス
- 提供ファイル：PDF（印刷可能）＋Excel（印刷可能）
- 同一企業内人数無制限でレポートファイルのご共有が可能です。
- シングルユーザライセンス
- 納品方法
- Eメール
- 納期
- レポートタイトルにより異なります。詳細はお気軽にお問い合わせください。
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはFortune Business Insightsの日本の販売代理店として、Fortune Business Insightsのレポートを取り扱っております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にSEMABIZまでご連絡ください。
最新調査レポート